http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
원발성 간암환자에서 간동맥 색전술의 치료효과 - 2. 중간 추적 생존율 -
고윤석(Youn Suck Koh),노임환(Im Hwan Roe),안정경(Jung Kyung Ahn),함준수(Joon Soo Hanm),이민호(Min Ho Lee),기춘석(Choon Suhk Kee),박경남(Kyung Nam Park),이은희(Eun Hee Lee),서흥석(Heung Suk Seo) 대한내과학회 1988 대한내과학회지 Vol.35 No.3
N/A Currently, primary hepatocellular carcinoma (HCC) is the second most common cause of cancer death in men in Korea. Generally, the tumor is unresectable due to underlying liver cirrhosis. As a palliative therapy of HCC, transcatheter arterial embolization (TAE) was performed in 53 patients (57 times) from April 19S5 until December 1986 at Hanyang University hospital, of which the conditions of only 35 patients could be followed after TAE therapy. We have analyzed the effectiveness of TAE therapy on these 35 patients. The results were as follows: In patient who didn't have tumor thrombosis in the first or second portal branches, the mean 8 months survival was 58.2%, while in patients with tumor thrombosis, it was 8.3%. The ratio of the tumor size to the liver measured by a planimeter in hepatic angiography was found to be meaningful in the prognosis; In patients with a ratio below 20%, the 6 months survival rate was 66.7%, and in patients with a ratio of 20% or more, it wis 43.4%, The results suggest that TAE is more beneficial in unresectable HCC which doesn't have tumor thrombosis in the first or second portal branches, and which has a ratio of tumor size to liver below 20% as measured by angiography.